Product Information
DAPTOMYCIN 500 MG VIAL is a generic product labeled by Par Health USA, LLC, priced at $20.7686 per EA under NDC 42023029510. Its NADAC has been published 8 times since Dec 3, 2025.
Strength
500 mg/1
Manufacturer
Par Health USA, LLCNDC
42023029510
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
1/21/2026
Active Ingredients
DAPTOMYCINApproval Type
New Drug (NDA)
FDA Application
NDA217630On Market Since
10/27/2025
Pharmacological Classes
Price Statistics
The NADAC for DAPTOMYCIN 500 MG VIAL has been published 8 times since Dec 3, 2025, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.7686 per EA |
|---|---|
| All-time high | $20.7686 (Jan 21, 2026) |
| All-time low | $20.1020 (Dec 3, 2025) |
| 52-week high | $20.7686 |
| 52-week low | $20.1020 |
| Median price | $20.4353 |
| Average price | $20.3936 |
| Largest weekly change | +1.7% (Dec 17, 2025) |
| Weeks tracked | 8 |
| Tracking since | Dec 3, 2025 |
Generic Alternatives
The matcher finds 11 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DAPTOMYCIN 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DAPTOMYCIN 500 MG VIAL, manufactured by Par Health USA, LLC, is $20.7686 per EA (NDC 42023029510), effective Jan 21, 2026.
How has the price of DAPTOMYCIN 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for DAPTOMYCIN 500 MG VIAL has risen 3.3%. It has been tracked across 8 weekly CMS publications since Dec 3, 2025.
What are the highest and lowest recorded NADAC prices for DAPTOMYCIN 500 MG VIAL?
Since Dec 3, 2025, the NADAC for DAPTOMYCIN 500 MG VIAL has ranged from a low of $20.1020 (Dec 3, 2025) to a high of $20.7686 (Jan 21, 2026), with a median of $20.4353 per EA.
Are there cheaper alternatives to DAPTOMYCIN 500 MG VIAL?
11 NADAC-published products share the same active ingredient, strength, and dosage form as DAPTOMYCIN 500 MG VIAL, but none are currently priced below it.
Who manufactures DAPTOMYCIN 500 MG VIAL?
DAPTOMYCIN 500 MG VIAL (NDC 42023029510) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification